Strengthening Lebanon's COVID-19 Response Project In Collaboration With The World Bank

Strengthening Lebanon's COVID-19 Response Project in Collaboration with the World Bank

Due to the unmet need for vaccines and the financial limitation of the GOL to meet the increasing health care needs, the “Strengthening Lebanon’s COVID-19 Response Project” will finance further purchase and deployment of equitable COVID-19 vaccines and needed supplies and activities to support the GOL COVID-19 response.

Strengthening Lebanon’s COVID-19 Response Project has a budget of US$29M and duration of two years and comprises the following components:
•   Component 1 – Procurement of COVID-19 vaccines and deployment:
This component will support the purchase of COVID-19 vaccines and related deployment activities.

•   Component 2- COVID-19 prevention, detection and case management:
This component will support other COVID-19 prevention, detection and case management activities.

•   Component 3 – System Strengthening, Monitoring and Management: This component will finance the project management unit, which includes at least: (i) financial management officers (FM), (ii) procurement and due diligence team; (iii) environmental and social officers; (iv) monitoring and evaluation officers and vi) Coordination. In addition, the component will support activities aimed at strengthening the health system in critical areas such as information systems, public health surveillance capacity, supply management/logistics, and expansion of primary health care settings.

Strengthening Lebanon’s Covid-19 Response (P178587)- Labor Management Procedures (LMP)- September 2022
Environmental and Social Management Framework (ESMF)- May 2022
Environmental and Social Commitment- (ESCP)- May 2022
Stakeholder Engagement Plan (SEP)- May 2022

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R01AA07	OTRIVIN	B	Xylometazoline HCl - 0.05%	0.05%	Drops	181,419 L.L
A03AX13	OVOL	B	Simethicone - 40mg/ml	40mg/ml	Drops	233,829 L.L
S01AA13	OPTIFUCIN VISCOUS	G	Fusidic acid - 1%	1%	Drops	208,296 L.L
S01GX09	OLOPAT	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	524,099 L.L
S01GX09	OLOPAT UD	G	Olopatadine (HCl) - 0.1%	0.1%	Drops solution	1,523,917 L.L
S02AA16	OFLOMED	G	Ofloxacin - 3mg/ml	3mg/ml	Drops solution	317,403 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Drops solution	1,343,843 L.L
S01AE01	OFLOX	B	Ofloxacin - 3mg/ml	0.3%	Drops solution	366,869 L.L
S01AE01	OFLOX	B	Ofloxacin - 0.3%	0.3%	Drops solution	366,869 L.L
S01AE01	OPTIFLOX	G	Ofloxacin - 3mg/ml	3mg/ml	Drops suspension	143,791 L.L
S01CA01	OPTIDEX T	G	Dexamethasone - 1mg/ml, Tobramycin - 3mg/ml		Drops suspension	266,081 L.L
M02AA15	OLFEN	G	Diclofenac sodium (diethylamine) - 1%	1%	Gel	268,769 L.L
G03CA03	OESTRODOSE	B	Estradiol (17 bêta estradiol anhydre) - 0.06%	0.06%	Gel	642,357 L.L
G03CA03	OESTRACLIN	G	Estradiol - 0.6mg/g	0.6mg/g	Gel	448,843 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
S01BA01	OZURDEX	B	Dexamethasone - 700mcg	700mcg	Implant	80,696,540 L.L
L04AA36	OCREVUS	BioTech	Ocrelizumab - 300mg/10ml	300mg/10ml	Injectable concentrate for solution	547,517,314 L.L
L04AA36	OCREVUS	BioTech	Ocrelizumab - 300mg/10ml	300mg/10ml	Injectable concentrate for solution	L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 100mg/20ml	5mg/ml	Injectable concentrated solution	8,471,583 L.L
L01XA03	OXALIPLATIN EBEWE	G	Oxaliplatin - 50mg/10ml	50mg/10ml	Injectable concentrated solution	3,405,297 L.L
L01XA03	OXALIPLATIN HOSPIRA	G	Oxaliplatin - 50mg/10ml	5mg/ml	Injectable concentrated solution	3,450,988 L.L
B05BA10	OLIMEL N9E	B	Glucose solution - 27.5%, Amino acids solution - 14.2%, Lipid emulsion - 20%, Sodium - 70mmol/2l, Potassium - 60mmol/2l, Magnesium - 8mmol/2l, Calcium - 7mmol/2l, Phosphate - 30mmol/2l, Acetate - 107mmol/2l, Chloride - 90mmol/2l, Azote - 18g/2l		Injectable emulsion	4,711,512 L.L
B02BD04	OCTANINE F	BioHuman	Plasma coagulation factor IX, human - 500IU	500IU	Injectable freeze dried powder + diluent	31,425,075 L.L
L01FD01	OGIVRI	BioTech	Trastuzumab - 440mg	440mg	Injectable lyophilised powder	80,027,615 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder	2,957,797 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	6,197,802 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 100mg	100mg	Injectable lyophilised powder for solution	5,915,595 L.L
L01XA03	OXALIPLATINO GP PHARM	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,956,454 L.L
L01XA03	OXALTIE	G	Oxaliplatin - 50mg	50mg	Injectable lyophilised powder for solution	2,957,797 L.L

...